GP6 and myelodysplastic syndrome: While platelet GPVI-related dysfunction is associated with a significant proportion of MDS cases, further studies are no doubt required to fully evaluate these changes temporally and in response to treatment in order to discover the molecular link between specific defects and platelet function, and to establish any prognostic value in future.